Evaluating STAT5 Phosphorylation as a Mean to Assess T Cell Proliferation.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2019
Historique:
received: 20 12 2018
accepted: 18 03 2019
entrez: 27 4 2019
pubmed: 27 4 2019
medline: 22 9 2020
Statut: epublish

Résumé

Here we present a simple and sensitive flow cytometric-based assay to assess T cell proliferation. Given the critical role STAT5A phosphorylation in T cell proliferation, we decided to evaluate phosphorylation of STAT5A as an indicator of T cell proliferation. We determined pSTAT5A in T cell treated with either CD3/CD28 or PHA. After stimulation, T cells from adult healthy donors displayed a strong long-lasting phosphorylation of STAT5A, reaching a peak value after 24 h. The median fluorescence intensity (MFI) of pSTAT5A increased from 112 ± 17 to 512 ± 278 (CD3/CD28) (24 h) and to 413 ± 123 (PHA) (24 h), the IL-2 receptor-α (CD25) expression was greatly enhanced and after 72 h T cell proliferation amounted to 52.3 ± 10.3% (CD3/CD28) and to 48.4 ± 9.7% (PHA). Treatment with specific JAK3 and STAT5 inhibitors resulted in a complete blockage of phosphorylation of STAT5A, CD25 expression, and suppression of T cell proliferation. Compared with currently available methods, STAT5A phosphorylation is well-suited to predict T cell proliferation. Moreover, the method presented here is not very time consuming (several hours) and delivers functional information from which conclusions about T cell proliferation can be drawn.

Identifiants

pubmed: 31024554
doi: 10.3389/fimmu.2019.00722
pmc: PMC6460883
doi:

Substances chimiques

STAT5 Transcription Factor 0
Janus Kinase 3 EC 2.7.10.2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

722

Références

Oncogene. 2000 May 15;19(21):2566-76
pubmed: 10851055
J Immunol Methods. 2000 Sep 21;243(1-2):147-54
pubmed: 10986412
Mol Pharmacol. 2000 Nov;58(5):1057-66
pubmed: 11040054
Biochim Biophys Acta. 2000 Oct 20;1498(1):1-18
pubmed: 11042346
J Immunol Methods. 2001 Jul 1;253(1-2):95-112
pubmed: 11384672
Immunol Cell Biol. 2002 Aug;80(4):351-7
pubmed: 12121224
Arthritis Res Ther. 2004;6(4):159-68
pubmed: 15225360
Cytokine Growth Factor Rev. 2004 Dec;15(6):435-55
pubmed: 15561601
Nat Rev Immunol. 2005 Jun;5(6):472-84
pubmed: 15928679
Science. 2005 Nov 18;310(5751):1159-63
pubmed: 16293754
PLoS One. 2007 Sep 26;2(9):e935
pubmed: 17895976
J Immunol. 2007 Oct 15;179(8):5301-8
pubmed: 17911616
J Clin Invest. 2008 Nov;118(11):3564-73
pubmed: 18982163
Cytometry A. 2010 Jul;77(7):607-13
pubmed: 20583270
J Immunol Methods. 2011 Feb 1;364(1-2):33-9
pubmed: 21036178
Cytometry A. 2011 Feb;79(2):95-101
pubmed: 21265003
Curr Opin Rheumatol. 2012 Sep;24(5):515-21
pubmed: 22820513
Cytometry A. 2012 Nov;81(11):1005-11
pubmed: 22997026
N Engl J Med. 2013 Jan 10;368(2):161-70
pubmed: 23301733
Evid Based Complement Alternat Med. 2013;2013:435916
pubmed: 23533483
Cytometry B Clin Cytom. 2013 May;84(3):135-42
pubmed: 23554222
Cytometry B Clin Cytom. 2014 May;86(3):191-206
pubmed: 24488780
PLoS One. 2014 Jan 30;9(1):e86790
pubmed: 24497979
Clin Exp Immunol. 2015 Jul;181(1):29-38
pubmed: 25736842
J Interferon Cytokine Res. 2016 Apr;36(4):226-37
pubmed: 26716518
J Immunol Methods. 2016 Mar;430:10-20
pubmed: 26780292
PLoS One. 2016 Dec 9;11(12):e0167215
pubmed: 27936140
F1000Res. 2017 Jan 11;6:32
pubmed: 28163905
J Allergy Clin Immunol. 2017 Nov;140(5):1439-1441.e9
pubmed: 28601682
Cytometry. 1997 Jan 1;27(1):71-6
pubmed: 9000587

Auteurs

Michael Bitar (M)

Medical Faculty, Institute of Clinical Immunology, University of Leipzig, Leipzig, Germany.

Andreas Boldt (A)

Medical Faculty, Institute of Clinical Immunology, University of Leipzig, Leipzig, Germany.

Marie-Theres Freitag (MT)

Medical Faculty, Institute of Clinical Immunology, University of Leipzig, Leipzig, Germany.

Bernd Gruhn (B)

Department of Pediatrics, Jena University Hospital, Jena, Germany.

Ulrike Köhl (U)

Medical Faculty, Institute of Clinical Immunology, University of Leipzig, Leipzig, Germany.
Hannover Medical School, Institute of Cellular Therapeutics, Hannover, Germany.
Fraunhofer Institute for Immunology and Cell Therapy (IZI), Leipzig, Germany.

Ulrich Sack (U)

Medical Faculty, Institute of Clinical Immunology, University of Leipzig, Leipzig, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH